205 related articles for article (PubMed ID: 25022285)
1. Early decrease in carotid plaque lipid content as assessed by magnetic resonance imaging during treatment of rosuvastatin.
Du R; Cai J; Zhao XQ; Wang QJ; Liu DQ; Leng WX; Gao P; Wu HM; Ma L; Ye P
BMC Cardiovasc Disord; 2014 Jul; 14():83. PubMed ID: 25022285
[TBL] [Abstract][Full Text] [Related]
2. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial.
Underhill HR; Yuan C; Zhao XQ; Kraiss LW; Parker DL; Saam T; Chu B; Takaya N; Liu F; Polissar NL; Neradilek B; Raichlen JS; Cain VA; Waterton JC; Hamar W; Hatsukami TS
Am Heart J; 2008 Mar; 155(3):584.e1-8. PubMed ID: 18294500
[TBL] [Abstract][Full Text] [Related]
3. MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course.
Zhao XQ; Dong L; Hatsukami T; Phan BA; Chu B; Moore A; Lane T; Neradilek MB; Polissar N; Monick D; Lee C; Underhill H; Yuan C
JACC Cardiovasc Imaging; 2011 Sep; 4(9):977-86. PubMed ID: 21920335
[TBL] [Abstract][Full Text] [Related]
4. [Effects of moderate dose rosuvastatin on carotid plaque in patients with diabetes mellitus evaluated by magnetic resonance imaging].
Du RX; Cai JM; Wang QJ; Luo LM; Wang XN; Cao RH; Wu HM; Ye P
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jun; 50(6):570-576. PubMed ID: 35705466
[No Abstract] [Full Text] [Related]
5. Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study.
Rollefstad S; Ikdahl E; Hisdal J; Olsen IC; Holme I; Hammer HB; Smerud KT; Kitas GD; Pedersen TR; Kvien TK; Semb AG
Arthritis Rheumatol; 2015 Jul; 67(7):1718-28. PubMed ID: 25778850
[TBL] [Abstract][Full Text] [Related]
6. Intensive lipid lowering therapy with titrated rosuvastatin yields greater atherosclerotic aortic plaque regression: Serial magnetic resonance imaging observations from RAPID study.
Yogo M; Sasaki M; Ayaori M; Kihara T; Sato H; Takiguchi S; Uto-Kondo H; Yakushiji E; Nakaya K; Komatsu T; Momiyama Y; Nagata M; Mochio S; Iguchi Y; Ikewaki K
Atherosclerosis; 2014 Jan; 232(1):31-9. PubMed ID: 24401214
[TBL] [Abstract][Full Text] [Related]
7. Carotid plaque regression following 6-month statin therapy assessed by 3T cardiovascular magnetic resonance: comparison with ultrasound intima media thickness.
Migrino RQ; Bowers M; Harmann L; Prost R; LaDisa JF
J Cardiovasc Magn Reson; 2011 Aug; 13(1):37. PubMed ID: 21812992
[TBL] [Abstract][Full Text] [Related]
8. Rationale and design of the carotid plaque in human for all evaluations with aggressive rosuvastatin therapy (CHALLENGER trial): evaluation by magnetic resonance imaging.
Miyauchi K; Takaya N; Hirose T; Ikeda F; Kawamori R; Ohishi H; Yoshida K; Yamamoto M; Arai H; Urabe T; Hattori N; Suzuki M; Maehara T; Sase K; Hatsukami TS; Yuan C; Daida H
Circ J; 2009 Jan; 73(1):111-5. PubMed ID: 19057091
[TBL] [Abstract][Full Text] [Related]
9. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
Nissen SE; Nicholls SJ; Sipahi I; Libby P; Raichlen JS; Ballantyne CM; Davignon J; Erbel R; Fruchart JC; Tardif JC; Schoenhagen P; Crowe T; Cain V; Wolski K; Goormastic M; Tuzcu EM;
JAMA; 2006 Apr; 295(13):1556-65. PubMed ID: 16533939
[TBL] [Abstract][Full Text] [Related]
10. Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.
Hong YJ; Jeong MH; Hachinohe D; Ahmed K; Choi YH; Cho SH; Hwang SH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
Circ J; 2011; 75(2):398-406. PubMed ID: 21157106
[TBL] [Abstract][Full Text] [Related]
11. Changes in carotid plaque tissue composition in subjects who continued and discontinued statin therapy.
Du R; Zhao XQ; Cai J; Cui B; Wu HM; Ye P
J Clin Lipidol; 2016; 10(3):587-93. PubMed ID: 27206946
[TBL] [Abstract][Full Text] [Related]
12. Serial magnetic resonance imaging detects a rapid reduction in plaque lipid content under PCSK9 inhibition with alirocumab.
Sun J; Lepor NE; Cantón G; Contreras L; Hippe DS; Isquith DA; Balu N; Kedan I; Simonini AA; Yuan C; Zhao XQ; Hatsukami TS
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1415-1422. PubMed ID: 33392875
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN.
Puri R; Libby P; Nissen SE; Wolski K; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Raichlen JS; Uno K; Kataoka Y; Tuzcu EM; Nicholls SJ
Eur Heart J Cardiovasc Imaging; 2014 Apr; 15(4):380-8. PubMed ID: 24448227
[TBL] [Abstract][Full Text] [Related]
14. Effect of intensive statin therapy on regression of carotid intima-media thickness in patients with subclinical carotid atherosclerosis (a prospective, randomized trial: PEACE (Pitavastatin Evaluation of Atherosclerosis Regression by Intensive Cholesterol-lowering Therapy) study).
Ikeda K; Takahashi T; Yamada H; Matsui K; Sawada T; Nakamura T; Matsubara H;
Eur J Prev Cardiol; 2013 Dec; 20(6):1069-79. PubMed ID: 22689416
[TBL] [Abstract][Full Text] [Related]
15. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
Crouse JR; Raichlen JS; Riley WA; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Bots ML;
JAMA; 2007 Mar; 297(12):1344-53. PubMed ID: 17384434
[TBL] [Abstract][Full Text] [Related]
16. High HbA1c levels correlate with reduced plaque regression during statin treatment in patients with stable coronary artery disease: results of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).
Daida H; Takayama T; Hiro T; Yamagishi M; Hirayama A; Saito S; Yamaguchi T; Matsuzaki M;
Cardiovasc Diabetol; 2012 Jul; 11():87. PubMed ID: 22831708
[TBL] [Abstract][Full Text] [Related]
17. Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.
Foody JM; Toth PP; Tomassini JE; Sajjan S; Ramey DR; Neff D; Tershakovec AM; Hu H; Tunceli K
Vasc Health Risk Manag; 2013; 9():719-27. PubMed ID: 24265554
[TBL] [Abstract][Full Text] [Related]
18. Impact of intensive lipid lowering on lipid profiles over time and tolerability in stable coronary artery disease: insights from a subanalysis of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).
Kawashiri MA; Yamagishi M; Sakamoto T; Takayama T; Hiro T; Daida H; Hirayama A; Saito S; Yamaguchi T; Matsuzaki M;
Cardiovasc Ther; 2013 Dec; 31(6):335-43. PubMed ID: 23409830
[TBL] [Abstract][Full Text] [Related]
19. Rosuvastatin reduces intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease: the Asymptomatic Carotid Atherosclerotic Disease in Manfredonia (ACADIM) Study.
Riccioni G; Bazzano LA; Bucciarelli T; Mancini B; di Ilio E; D'Orazio N
Expert Opin Pharmacother; 2008 Oct; 9(14):2403-8. PubMed ID: 18778179
[TBL] [Abstract][Full Text] [Related]
20. Early intervention with rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome: analysis using integrated backscatter IVUS (ELAN study).
Otagiri K; Tsutsui H; Kumazaki S; Miyashita Y; Aizawa K; Koshikawa M; Kasai H; Izawa A; Tomita T; Koyama J; Ikeda U
Circ J; 2011; 75(3):633-41. PubMed ID: 21266787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
